Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT00287729 · COMPLETED

Trial details

NCT number: NCT00287729
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2006-04-01
Primary completion: 2008-11-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.